Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells

Marek J. Kaminski, Ponciano D Cruz, Paul R. Bergstresser, Akira Takashima

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Dendritic epidermal T-cells (DETC) are a unique population of T-cells that reside normally in mouse epidermis and express a γδ T-cell receptor. We have reported previously that DETC acquire in culture the capacity to lyse the YAC-1 lymphoma, a conventional target for natural killer cells. The aim of the present study was to characterize this cytotoxic potential, using a spectrum of skin-derived mouse tumors. Cytotoxicity was measured by a 51Cr release assay and by the visual assessment of target cell lysis. Long-term DETC lines, established from CBA, AKR, and BALB/c mice by mitogenic stimulation and repeated feeding with interleukin 2 (5 units/ml), were used as effectors. Skin-derived tumor targets included 5 melanoma lines and the transformed keratinocyte line Pam 212. Each DETC line lysed skin-derived tumors as well as YAC-1 targets effectively in the 18-h 51Cr release assay, and target lysis occurred in a non-major histocompatibility complex-restricted manner. By contrast, freshly isolated spleen cells lysed YAC-1 but not skin tumor targets. Moreover, confluent monolayers of melanoma or Pam 212 targets were disrupted completely by added DETC lines but not by spleen cells. The cytolytic activity of DETC appeared to be specific for tumor cells, since normal mouse keratinocyte monolayers remained intact under the same conditions. Finally, DETC freshly isolated from skin failed to exhibit significant cytotoxicity but acquired this capacity 10-14 days after mitogenic stimulation and feeding with interleukin 2 (5 units/ml). We conclude that DETC possess the potential to recognize, bind, and lyse tumor cells that originate in skin.

Original languageEnglish (US)
Pages (from-to)4014-4019
Number of pages6
JournalCancer Research
Volume53
Issue number17
StatePublished - Sep 1 1993

Fingerprint

Langerhans Cells
T-Lymphocytes
Skin
Neoplasms
Interleukin-5
Keratinocytes
Cell Line
Interleukin-2
Melanoma
Spleen
T-Cell Antigen Receptor
Major Histocompatibility Complex
Epidermis
Natural Killer Cells
Lymphoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kaminski, M. J., Cruz, P. D., Bergstresser, P. R., & Takashima, A. (1993). Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Research, 53(17), 4014-4019.

Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. / Kaminski, Marek J.; Cruz, Ponciano D; Bergstresser, Paul R.; Takashima, Akira.

In: Cancer Research, Vol. 53, No. 17, 01.09.1993, p. 4014-4019.

Research output: Contribution to journalArticle

Kaminski, MJ, Cruz, PD, Bergstresser, PR & Takashima, A 1993, 'Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells', Cancer Research, vol. 53, no. 17, pp. 4014-4019.
Kaminski MJ, Cruz PD, Bergstresser PR, Takashima A. Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Research. 1993 Sep 1;53(17):4014-4019.
Kaminski, Marek J. ; Cruz, Ponciano D ; Bergstresser, Paul R. ; Takashima, Akira. / Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. In: Cancer Research. 1993 ; Vol. 53, No. 17. pp. 4014-4019.
@article{0232d37d122a4f138858ee2b9e25b1b4,
title = "Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells",
abstract = "Dendritic epidermal T-cells (DETC) are a unique population of T-cells that reside normally in mouse epidermis and express a γδ T-cell receptor. We have reported previously that DETC acquire in culture the capacity to lyse the YAC-1 lymphoma, a conventional target for natural killer cells. The aim of the present study was to characterize this cytotoxic potential, using a spectrum of skin-derived mouse tumors. Cytotoxicity was measured by a 51Cr release assay and by the visual assessment of target cell lysis. Long-term DETC lines, established from CBA, AKR, and BALB/c mice by mitogenic stimulation and repeated feeding with interleukin 2 (5 units/ml), were used as effectors. Skin-derived tumor targets included 5 melanoma lines and the transformed keratinocyte line Pam 212. Each DETC line lysed skin-derived tumors as well as YAC-1 targets effectively in the 18-h 51Cr release assay, and target lysis occurred in a non-major histocompatibility complex-restricted manner. By contrast, freshly isolated spleen cells lysed YAC-1 but not skin tumor targets. Moreover, confluent monolayers of melanoma or Pam 212 targets were disrupted completely by added DETC lines but not by spleen cells. The cytolytic activity of DETC appeared to be specific for tumor cells, since normal mouse keratinocyte monolayers remained intact under the same conditions. Finally, DETC freshly isolated from skin failed to exhibit significant cytotoxicity but acquired this capacity 10-14 days after mitogenic stimulation and feeding with interleukin 2 (5 units/ml). We conclude that DETC possess the potential to recognize, bind, and lyse tumor cells that originate in skin.",
author = "Kaminski, {Marek J.} and Cruz, {Ponciano D} and Bergstresser, {Paul R.} and Akira Takashima",
year = "1993",
month = "9",
day = "1",
language = "English (US)",
volume = "53",
pages = "4014--4019",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells

AU - Kaminski, Marek J.

AU - Cruz, Ponciano D

AU - Bergstresser, Paul R.

AU - Takashima, Akira

PY - 1993/9/1

Y1 - 1993/9/1

N2 - Dendritic epidermal T-cells (DETC) are a unique population of T-cells that reside normally in mouse epidermis and express a γδ T-cell receptor. We have reported previously that DETC acquire in culture the capacity to lyse the YAC-1 lymphoma, a conventional target for natural killer cells. The aim of the present study was to characterize this cytotoxic potential, using a spectrum of skin-derived mouse tumors. Cytotoxicity was measured by a 51Cr release assay and by the visual assessment of target cell lysis. Long-term DETC lines, established from CBA, AKR, and BALB/c mice by mitogenic stimulation and repeated feeding with interleukin 2 (5 units/ml), were used as effectors. Skin-derived tumor targets included 5 melanoma lines and the transformed keratinocyte line Pam 212. Each DETC line lysed skin-derived tumors as well as YAC-1 targets effectively in the 18-h 51Cr release assay, and target lysis occurred in a non-major histocompatibility complex-restricted manner. By contrast, freshly isolated spleen cells lysed YAC-1 but not skin tumor targets. Moreover, confluent monolayers of melanoma or Pam 212 targets were disrupted completely by added DETC lines but not by spleen cells. The cytolytic activity of DETC appeared to be specific for tumor cells, since normal mouse keratinocyte monolayers remained intact under the same conditions. Finally, DETC freshly isolated from skin failed to exhibit significant cytotoxicity but acquired this capacity 10-14 days after mitogenic stimulation and feeding with interleukin 2 (5 units/ml). We conclude that DETC possess the potential to recognize, bind, and lyse tumor cells that originate in skin.

AB - Dendritic epidermal T-cells (DETC) are a unique population of T-cells that reside normally in mouse epidermis and express a γδ T-cell receptor. We have reported previously that DETC acquire in culture the capacity to lyse the YAC-1 lymphoma, a conventional target for natural killer cells. The aim of the present study was to characterize this cytotoxic potential, using a spectrum of skin-derived mouse tumors. Cytotoxicity was measured by a 51Cr release assay and by the visual assessment of target cell lysis. Long-term DETC lines, established from CBA, AKR, and BALB/c mice by mitogenic stimulation and repeated feeding with interleukin 2 (5 units/ml), were used as effectors. Skin-derived tumor targets included 5 melanoma lines and the transformed keratinocyte line Pam 212. Each DETC line lysed skin-derived tumors as well as YAC-1 targets effectively in the 18-h 51Cr release assay, and target lysis occurred in a non-major histocompatibility complex-restricted manner. By contrast, freshly isolated spleen cells lysed YAC-1 but not skin tumor targets. Moreover, confluent monolayers of melanoma or Pam 212 targets were disrupted completely by added DETC lines but not by spleen cells. The cytolytic activity of DETC appeared to be specific for tumor cells, since normal mouse keratinocyte monolayers remained intact under the same conditions. Finally, DETC freshly isolated from skin failed to exhibit significant cytotoxicity but acquired this capacity 10-14 days after mitogenic stimulation and feeding with interleukin 2 (5 units/ml). We conclude that DETC possess the potential to recognize, bind, and lyse tumor cells that originate in skin.

UR - http://www.scopus.com/inward/record.url?scp=0027293952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027293952&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 4014

EP - 4019

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 17

ER -